The current valuation score of Artiva Biotherapeutics Inc is 8.85, ranking 46 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.85, which is -91.45% below the recent high of -0.24 and -280.09% above the recent low of -10.82.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.